Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LPXN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NEXN-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GATA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GABRA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRLH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA1671 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MKRN7P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSGALNACT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAP1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGF7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNK7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RGS13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITPKB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FCRL4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MMP14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLAMF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on